Ultragenyx Pharmaceutical | RARE - Stock

Stock Price
23.12
Daily Change
-0.03 -0.13%
Monthly
2.26%
Yearly
-31.82%
Q2 Forecast
21.77

Ultragenyx Pharmaceutical reported $52.2M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
BioCryst Pharmaceuticals USD 5.4M 166K Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
Insmed USD 132.07M 11.1M Dec/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Kyowa Hakko Kirin JPY 72.86B 304M Jun/2025
MacroGenics USD 7.91M 840K Dec/2025
Moderna USD 332M 92M Sep/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025